Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-28 6:47 pm Purchase | 2024-06-26 | 13G | Cytosorbents Corporation CTSO | Avenue Venture Opportunities Fund, L.P. | 3,755,273 5.700% | 3,755,273 (New Position) | Filing History |
| 2025-04-30 10:59 am Sale | 2025-03-31 | 13G | Cytosorbents Corporation CTSO | The Vanguard Group | 1,949,551 3.110% | -1,949,551 (-50.00%) | Filing History |
| 2025-04-17 2:22 pm Purchase | 2025-03-31 | 13G | Cytosorbents Corporation CTSO | Skylands Capital LLC | 3,002,702 4.800% | 221,080 (+7.95%) | Filing History |
| 2025-02-14 10:22 am Purchase | 2024-12-31 | 13G | Cytosorbents Corporation CTSO | AVENIR CORP | 3,093,946 5.700% | 42,544 (+1.39%) | Filing History |
| 2025-01-31 6:49 pm Purchase | 2024-12-31 | 13G | Cytosorbents Corporation CTSO | The Vanguard Group | 3,899,102 7.130% | 1,942,274 (+99.26%) | Filing History |
| 2025-01-17 4:05 pm Purchase | 2025-01-13 | 13G | Cytosorbents Corporation CTSO | Thomas A. Satterfield, Jr. | 3,998,867 6.560% | 3,998,867 (New Position) | Filing History |
| 2025-01-07 1:26 pm Sale | 2024-12-31 | 13G | Cytosorbents Corporation CTSO | Skylands Capital LLC | 2,781,622 5.100% | -472,591 (-14.52%) | Filing History |
| 2024-11-14 4:48 pm Sale | 2024-09-30 | 13G | Cytosorbents Corporation CTSO | Granahan Investment Management LLC | 2,094,882 3.850% | -1,523,261 (-42.10%) | Filing History |
| 2024-02-14 4:42 pm Purchase | 2023-12-31 | 13G | Cytosorbents Corporation CTSO | AVENIR CORP | 3,051,402 6.870% | 604,313 (+24.70%) | Filing History |
| 2024-02-14 09:00 am Purchase | 2023-12-31 | 13G | Cytosorbents Corporation CTSO | Granahan Investment Management LLC | 3,618,143 6.930% | 3,618,143 (New Position) | Filing History |
| 2024-01-08 3:00 pm Purchase | 2023-12-31 | 13G | Cytosorbents Corporation CTSO | Skylands Capital LLC | 3,254,213 7.300% | 712,122 (+28.01%) | Filing History |
| 2023-02-14 1:08 pm Purchase | 2022-12-31 | 13G | Cytosorbents Corporation CTSO | AVENIR CORP | 2,447,089 5.610% | 259,307 (+11.85%) | Filing History |
| 2023-02-09 11:16 am Sale | 2022-12-30 | 13G | Cytosorbents Corporation CTSO | The Vanguard Group | 1,956,828 4.480% | -252,337 (-11.42%) | Filing History |
| 2023-02-07 2:28 pm Purchase | 2022-12-31 | 13G | Cytosorbents Corporation CTSO | Skylands Capital LLC | 2,542,091 5.800% | 2,542,091 (New Position) | Filing History |
| 2022-08-11 08:39 am Purchase | 2022-07-26 | 13G | Cytosorbents Corporation CTSO | AVENIR CORP | 2,187,782 5.020% | 30,949 (+1.43%) | Filing History |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | Cytosorbents Corporation CTSO | BlackRock Inc. BLK | 744,958 1.700% | -1,886,252 (-71.69%) | Filing History |
| 2022-06-27 5:34 pm Sale | 2022-05-26 | 13G | Cytosorbents Corporation CTSO | AVENIR CORP | 2,156,833 4.950% | -20,313 (-0.93%) | Filing History |
| 2022-04-22 5:34 pm Purchase | 2022-03-22 | 13G | Cytosorbents Corporation CTSO | AVENIR CORP | 2,177,146 5.000% | 89,075 (+4.27%) | Filing History |
| 2022-02-09 3:43 pm Sale | 2021-12-31 | 13G | Cytosorbents Corporation CTSO | The Vanguard Group | 2,209,165 5.080% | -12,441 (-0.56%) | Filing History |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | Cytosorbents Corporation CTSO | BlackRock Inc. BLK | 2,631,210 6.100% | -131,078 (-4.75%) | Filing History |